Biologic Input Output Systems

Executive Summary

Biologic Input Output Systems is developing a Universal Neural Interface that acts as a 'USB port for the human body,' connecting the peripheral nervous system to external devices such as robotic limbs and digital systems. Founded in 2018 and based in San Francisco, the company aims to restore natural, intuitive control for individuals with paralysis or limb loss. By targeting the peripheral nerves, its approach potentially offers lower surgical risk and higher signal resolution compared to invasive brain-computer interfaces. The technology sits at the intersection of digital health, AI, and diagnostics, with applications in prosthetics, neurorehabilitation, and human-machine interaction. Despite early-stage status and limited public funding history, the company's concept addresses a large unmet need in the neural interface market, which is projected to grow rapidly. Key challenges include regulatory approval, manufacturing scalability, and competition from well-funded players like Neuralink and Synchron. However, if successful, Biologic Input Output Systems could establish a new standard for bidirectional neural communication, enabling seamless integration of biological and electronic systems. The platform's versatility also opens avenues beyond medical use, including consumer electronics and augmented reality. Near-term execution will depend on clinical validation and strategic partnerships to accelerate development and adoption.

Upcoming Catalysts (preview)

• H1 2027First-in-human clinical trial initiation55% success
• H2 2026Strategic partnership with a major prosthetics or robotics manufacturer45% success
• Q4 2026FDA Breakthrough Device Designation70% success